{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:29:03Z","timestamp":1786123743517,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1227\/neu.0b013e31828cf619","type":"journal-article","created":{"date-parts":[[2013,2,20]],"date-time":"2013-02-20T05:03:23Z","timestamp":1361336603000},"page":"960-970","source":"Crossref","is-referenced-by-count":40,"title":["A Case Series of Primary Central Nervous System Posttransplantation Lymphoproliferative Disorder"],"prefix":"10.1227","volume":"72","author":[{"given":"Wendell","family":"Lake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie E.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabassum","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahriar","family":"Salamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa K.","family":"Ba\u015fkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"1","key":"-20230323","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/neuonc\/nor186","article-title":". Cognitive functions in primary CNS lymphoma after single or combined modality regimens.","volume":"14","author":"Correa","year":"2012","journal-title":"Neuro Oncol"},{"key":"-20230323","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.transproceed.2004.12.130","article-title":". Post-transplant lymphoproliferative disorder: significance of central nervous system involvement.","volume":"37","author":"Buell","year":"2005","journal-title":"Transplant Proc"},{"issue":"2","key":"R1-23-20230323","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00007890-199501000-00016","article-title":"Central nervous system lymphomas in organ allograft recipients.","volume":"59","author":"Penn","year":"1995","journal-title":"Transplantation"},{"issue":"2","key":"R2-23-20230323","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1309\/N82CTQ1J0XEVEFQB","article-title":"Primary central nervous system posttransplant lymphoproliferative disorders.","volume":"121","author":"Castellano-Sanchez","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"R3-23-20230323","first-page":"1135","article-title":". Neurologic complications after allogeneic bone marrow transplantation.","volume":"18","author":"Gallardo","year":"1996","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"R4-23-20230323","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1080\/10428190701608657","article-title":". An overview of the pathogenesis and natural history of post-transplant T-cell lymphoma correction in Leukemia Lymphoma, June 2007; 48(6): 1237-1241).","volume":"48","author":"Jamali","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"R5-23-20230323","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.surneu.2007.04.009","article-title":"Primary central nervous system lymphoma presenting as an acute massive intracerebral hemorrhage: case report with immunohistochemical study.","volume":"70","author":"Kim","year":"2008","journal-title":"Surg Neurol"},{"issue":"6","key":"R6-23-20230323","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/01.TP.0000079253.06061.52","article-title":". Primary brain lymphomas after kidney transplantation: presentation and outcome.","volume":"76","author":"Snanoudj","year":"2003","journal-title":"Transplantation"},{"issue":"2","key":"R7-23-20230323","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3171\/jns.2000.92.2.0261","article-title":". Primary intracerebral malignant lymphoma: report of 248 cases.","volume":"92","author":"Bataille","year":"2000","journal-title":"J Neurosurg"},{"issue":"24","key":"R8-23-20230323","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1200\/JCO.2002.11.013","article-title":"Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.","volume":"20","author":"DeAngelis","year":"2002","journal-title":"J Clin Oncol"},{"issue":"6","key":"R9-23-20230323","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1634\/theoncologist.11-6-674","article-title":"Post-transplant lymphoproliferative disorders.","volume":"11","author":"LaCasce","year":"2006","journal-title":"Oncologist"},{"issue":"4","key":"R10-23-20230323","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/cncr.24834","article-title":"Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report.","volume":"116","author":"Cavaliere","year":"2010","journal-title":"Cancer"},{"key":"R11-23-20230323","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.med.56.082103.104727","article-title":"Post-transplant lymphoproliferative disorders.","volume":"56","author":"Gottschalk","year":"2005","journal-title":"Annu Rev Med"},{"issue":"10","key":"R12-23-20230323","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1046\/j.0007-1323.2001.01924.x","article-title":"Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients.","volume":"88","author":"Libertiny","year":"2001","journal-title":"Br J Surg"},{"issue":"1","key":"R13-23-20230323","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.critrevonc.2005.03.015","article-title":"Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.","volume":"56","author":"Taylor","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"R14-23-20230323","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1200\/JCO.1998.16.3.859","article-title":"Long-term survival in primary CNS lymphoma.","volume":"16","author":"Abrey","year":"1998","journal-title":"J Clin Oncol"},{"issue":"17","key":"R15-23-20230323","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1200\/JCO.2000.18.17.3144","article-title":"Treatment for primary CNS lymphoma: the next step.","volume":"18","author":"Abrey","year":"2000","journal-title":"J Clin Oncol"},{"issue":"4","key":"R16-23-20230323","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1200\/JCO.1992.10.4.635","article-title":"Combined modality therapy for primary CNS lymphoma.","volume":"10","author":"DeAngelis","year":"1992","journal-title":"J Clin Oncol"},{"issue":"2","key":"R17-23-20230323","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3171\/jns.1994.81.2.0188","article-title":"Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome.","volume":"81","author":"Glass","year":"1994","journal-title":"J Neurosurg"},{"issue":"11","key":"R18-23-20230323","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3324\/haematol.11360","article-title":". Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease.","volume":"92","author":"Gonzalez-Barca","year":"2007","journal-title":"Haematologica"},{"issue":"1","key":"R19-23-20230323","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/cncr.11035","article-title":". Is whole-brain irradiation necessary for primary central nervous system lymphoma Patterns of recurrence after partial-brain irradiation.","volume":"97","author":"Shibamoto","year":"2003","journal-title":"Cancer"},{"issue":"4","key":"R20-23-20230323","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1215\/15228517-2-4-229","article-title":"Posttransplant primary CNS lymphoma.","volume":"2","author":"Phan","year":"2000","journal-title":"Neuro Oncol"},{"issue":"3","key":"R21-23-20230323","first-page":"563","article-title":"The variable MR appearance of primary lymphoma of the central nervous system: comparison with histopathologic features.","volume":"18","author":"Johnson","year":"1997","journal-title":"AJNR Am J Neuroradiol"},{"issue":"12","key":"R22-23-20230323","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/neuonc\/nos159","article-title":"Surgery for primary CNS lymphoma Challenging a paradigm.","volume":"14","author":"Weller","year":"2012","journal-title":"Neuro Oncol"},{"issue":"9","key":"R23-23-20230323","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1200\/JCO.1998.16.9.3000","article-title":". Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma.","volume":"16","author":"Sandor","year":"1998","journal-title":"J Clin Oncol"},{"issue":"30","key":"R24-23-20230323","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2007.12.5062","article-title":". Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma.","volume":"25","author":"Shah","year":"2007","journal-title":"J Clin Oncol"},{"issue":"11","key":"R25-23-20230323","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S1470-2045(10)70229-1","article-title":". High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.","volume":"11","author":"Thiel","year":"2010","journal-title":"Lancet Oncol"},{"issue":"8","key":"R26-23-20230323","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1182\/blood-2005-01-0377","article-title":". Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study.","volume":"107","author":"Choquet","year":"2006","journal-title":"Blood"},{"issue":"10","key":"R27-23-20230323","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1080\/10428190802311375","article-title":"Sustained remission and long-term survival of secondary central nervous system involvement by aggressive B-cell lymphoma after combination treatment of systemic high-dose chemotherapy and intrathecal rituximab.","volume":"49","author":"Liu","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"R28-23-20230323","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s12094-010-0580-y","article-title":"Ocular relapse of primary brain lymphoma in immunocompetent patient, treated with intrathecal rituximab.","volume":"12","author":"Maximiano Alonso","year":"2010","journal-title":"Clin Transl Oncol"},{"issue":"10","key":"R29-23-20230323","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1345\/aph.1P197","article-title":"Role of intrathecal rituximab and trastuzumab in the management of leptomeningeal carcinomatosis.","volume":"44","author":"Perissinotti","year":"2010","journal-title":"Ann Pharmacother"},{"issue":"11","key":"R30-23-20230323","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1200\/JCO.2006.09.7311","article-title":". Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma.","volume":"25","author":"Rubenstein","year":"2007","journal-title":"J Clin Oncol"},{"issue":"4","key":"R31-23-20230323","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/pbc.21297","article-title":"Intrathecal rituximab treatment for pediatric post-transplant lymphoproliferative disorder of the central nervous system.","volume":"50","author":"van de Glind","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"R32-23-20230323","doi-asserted-by":"crossref","first-page":"6204","DOI":"10.4049\/jimmunol.160.12.6204","article-title":". Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients.","volume":"160","author":"Haque","year":"1998","journal-title":"J Immunol"},{"issue":"18","key":"R33-23-20230323","doi-asserted-by":"crossref","first-page":"10391","DOI":"10.1073\/pnas.96.18.10391","article-title":". Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.","volume":"96","author":"Khanna","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"R34-23-20230323","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1182\/blood-2006-05-021782","article-title":". Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs).","volume":"108","author":"Savoldo","year":"2006","journal-title":"Blood"},{"issue":"4","key":"R35-23-20230323","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2006-12-063008","article-title":". Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial.","volume":"110","author":"Haque","year":"2007","journal-title":"Blood"}],"container-title":["Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neurosurgery\/article-pdf\/72\/6\/960\/32594928\/neurosurgery-72-6-960.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ovid.com\/00006123-201306000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:39:57Z","timestamp":1786120797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006123-201306000-00023"}},"subtitle":["Imaging and Clinical Characteristics"],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1227\/neu.0b013e31828cf619","relation":{},"ISSN":["0148-396X"],"issn-type":[{"value":"0148-396X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}